RecallRadar

FDA Drug recall D-1325-2015

Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd

On 2015-08-19 the FDA classified a Class II recall of Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd by Dr Reddy S Laboratories, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1325-2015
ClassificationClass II
Statusterminated
Initiated2015-08-03
Published2015-08-19
Last updated2026-09-13 11:51 UTC
CompanyDr Reddy S Laboratories
DistributionUS

Product

Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-352-60

Reason

Failed Dissolution Specifications

Identifiers

ndc55111-352-30
ndc55111-352-60
ndc55111-352-01
ndc55111-352-05
ndc55111-353-30
ndc55111-353-60
ndc55111-353-01
ndc55111-353-05
ndc55111-354-30
ndc55111-354-60
ndc55111-354-01
ndc55111-354-05
ndc55111-355-30
ndc55111-355-60
ndc55111-355-01
ndc55111-355-05
code_infoLot #: C501342; Exp 01/2017

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1325-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.